Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Overnight Hypertonic Saline via tPAD in Cystic Fibrosis
NCT02141191Phase 1Completed
- Sponsor
- University of Pittsburgh
- Start
- Jun 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of hypertonic saline in cystic fibrosis (CF) (2 arms), sponsored by University of Pittsburgh. Primary endpoint: Mucociliary Clearance at 6 hours. Started Jun 2014; status: completed.
02
Drugs
hypertonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02141191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141191.